These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
4. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. Kobashi Y; Matsushima T Respiration; 2007; 74(4):394-400. PubMed ID: 16954651 [TBL] [Abstract][Full Text] [Related]
5. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment]. Kobashi Y; Oka M Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014 [TBL] [Abstract][Full Text] [Related]
7. Pneumonectomy for nontuberculous mycobacterial infections. Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N Ann Thorac Surg; 2004 Aug; 78(2):399-403. PubMed ID: 15276484 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of non-tuberculous pulmonary mycobacteriosis]. Sakatani M; Nakajima Y Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
10. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis]. Kuwabara K; Watanabe Y; Wada K; Tsuchiya T Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303 [TBL] [Abstract][Full Text] [Related]
12. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. Sato K; Ebe T Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891 [TBL] [Abstract][Full Text] [Related]
13. Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. Shiraishi Y; Nakajima Y; Takasuna K; Hanaoka T; Katsuragi N; Konno H Eur J Cardiothorac Surg; 2002 Feb; 21(2):314-8. PubMed ID: 11825742 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907 [TBL] [Abstract][Full Text] [Related]
15. [Perspective of pulmonary MAC infection treatment]. Kurashima A Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124 [TBL] [Abstract][Full Text] [Related]